Montaser Shaheen, M.D.

8% more Medicare Part D claims than the average hematology (internal medicine) physician in 2024

534 Medicare Part D claims for 107 beneficiaries, against an average of 496 among the 1,036 providers of this specialty who prescribed in Part D. Brand-name drugs were 40% of claims. 23 claims were for opioids.

Most prescribed

1. Cabometyx99 claims
2. Amlodipine Besylate36 claims
3. Methylprednisolone30 claims
4. Levothyroxine Sodium28 claims
5. Hydrocortisone23 claims
6. Anastrozole18 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 79.5 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

2 hospitals and group practices

1. Gila Regional Medical CenterSilver City, NM · Critical Access Hospitals2 of 5 stars
2. University OF Texas Health Science Center AT San AntonioSan Antonio, TX

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.